Oncorus

About:

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Website: http://www.oncorus.com

Twitter/X: OncorusInc

Top Investors: Deerfield, Perceptive Advisors, Surveyor Capital, IMM Investment, MPM Capital

Description:

Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.

Total Funding Amount:

$218M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2015-04-01

Contact Email:

info(AT)oncorus.com

Founders:

Cyrus Mozayeni, Kenneth Greenberg, Mitchell Finer

Number of Employees:

51-100

Last Funding Date:

2022-04-05

IPO Status:

Public

Industries:

© 2025 bioDAO.ai